| BG |
Report |
Adjusted EPS |
BEAT |
pred ~$1.96 vs. cons $1.88 |
MEDIUM |
| BG |
Report |
Adjusted Segment EBIT |
BEAT |
pred ~$705m vs. cons $675m |
MEDIUM |
| BG |
Report |
Soybean plus Softseed Processing & Refining adjusted EBIT |
BEAT |
pred ~$590m vs. cons $560m |
MEDIUM |
| BG |
Guide |
FY2026 adjusted EPS |
UNCHANGED |
guide ~$9.25 vs. cons $9.25 (FY2026) |
MEDIUM |
| BG |
Guide |
FY2026 net interest expense |
UNCHANGED |
guide ~$640m vs. cons $640m (FY2026) |
MEDIUM |
| BG |
Guide |
Viterra cost-synergy realization |
BETTER |
guide ~$215m vs. cons $200m (FY2026) |
MEDIUM |
| BG |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
MEDIUM |
| BG |
Return |
5-day cumulative residual |
+2.0% (STABILIZE) |
A ~$1.96 reported EPS versus $1.88 consensus and ~$705m adjusted Segment EBIT versus $675m support an initial positive move, but an unchanged ~$9.25 FY2026 midpoint versus $9.25 consensus leaves limited out-period estimate upside; stronger ~$215m synergy realization versus $200m offsets, but does not eliminate, the risk that inverted curves and higher financing costs constrain 2H revisions. |
MEDIUM |